Concepedia

Gillis Carrigan

GC

10

Publications

1.1K

Citations

10

H-Index

1998

Active since

Affiliations

Flatiron Health (United States)(Current)

Harvard University

RTI Health Solutions

University of Colorado Denver

RTI International

Gillis Carrigan is an author at Flatiron Health (United States) specializing in medicine, public health, and substance abuse.

ORCID

Top concepts

Publications per year

1998–2022

10

Publications

10

The Xolair Pregnancy Registry (EXPECT): The safety of omalizumab use during pregnancy

Jennifer A. Namazy, Michael D. Cabana, Angela E. Scheuerle et al. · Journal of Allergy and Clinical Immunology · 2014 · 240 citations

, , +10

Incidence of malignancy in patients with moderate-to-severe asthma treated with or without omalizumab

Aidan A. Long, Abdelkader Rahmaoui, Kenneth J. Rothman et al. · Journal of Allergy and Clinical Immunology · 2014 · 218 citations · Full text

Development and Validation of a High‐Quality Composite Real‐World Mortality Endpoint

Melissa D. Curtis, Sandra D. Griffith, Melisa Tucker et al. · Health Services Research · 2018 · 208 citations · Full text

Cardiovascular and cerebrovascular events among patients receiving omalizumab: Results from EXCELS, a prospective cohort study in moderate to severe asthma

Carlos Iribarren, Abdelkader Rahmaoui, Aidan A. Long et al. · Journal of Allergy and Clinical Immunology · 2016 · 112 citations

Using Electronic Health Records to Derive Control Arms for Early Phase Single‐Arm Lung Cancer Trials: Proof‐of‐Concept in Randomized Controlled Trials

Gillis Carrigan, Samuel Whipple, William B. Capra et al. · Clinical Pharmacology & Therapeutics · 2019 · 98 citations · Full text

Rows per page

1–5 of 10